2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
139
Neoplasms
118
Prostatic Neoplasms
64
Lung Neoplasms
48
Head and Neck Neoplasms
46
Colorectal Neoplasms
38
Ovarian Neoplasms
33
Uterine Cervical Neoplasms
29
Endometrial Neoplasms
23
Motor Activity
22
Neoplasm Metastasis
20
Multiple Myeloma
20
Pancreatic Neoplasms
19
Brain Neoplasms
19
Rectal Neoplasms
18
Lymphoma
17
Colonic Neoplasms
17
Pain
16
Gastrointestinal Neoplasms
16
Fatigue
16
Carcinoma, Non-Small-Cell Lung
16
Leukemia
15
Depression
15
Oropharyngeal Neoplasms
13
Melanoma
13
Anxiety Disorders
13
Urinary Bladder Neoplasms
12
Hematologic Neoplasms
12
Esophageal Neoplasms
12
Stomach Neoplasms
11
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Surveys and Questionnaires
×
Clear all
NCT05690958
2023-04-05
ACCEPT-survey
Radboud University Medical Center
Unknown
2,088 enrolled